Colonic Diseases Clinical Trial
Official title:
Randomised, Controlled Trial of Intravenous Saline Pre-hydration in Patients Undergoing Outpatient Colonoscopy
Colonoscopy and sedation are frequently accompanied by hypotension, which reduces the amount
of sedation able to be employed. Blood pressure is restored by the infusion of intravenous
normal saline. Prophylactic infusion of normal saline may enhance the colonoscopy completion
rate, and patient comfort during colonoscopy and during the recovery from colonoscopy.
The investigators propose randomising consenting adult patients attending outpatient
colonoscopy to one of two treatment arms:
(i) A control arm
(ii) A treatment arm, with pre-hydration with an infusion of 1.0 litre of normal saline
immediately prior to colonoscopy.
Outcome measures include colonoscopy completion rates, hypotension during or after
colonoscopy, and patient ratings of comfort and satisfaction.
Outpatient colonoscopy is a generally well-tolerated elective procedure. Colonoscopy
completion rate is governed in part by patient comfort, which is enhanced by adequate
sedation. In addition, comfort following colonoscopy determines timely recovery from the
procedure and return to usual activities.
Colonoscopy and sedation are frequently accompanied by hypotension (systolic blood pressure
less than 100 mm Hg), which reduces the amount of sedation able to be employed. Where
apparent, blood pressure is restored by infusion of intravenous normal saline. We have
observed that hypotension is relatively common and may be present at or shortly after the
commencement of the procedure, suggesting that many patients undergoing colonoscopy have
reduced blood volume. Therefore, prophylactic infusion of normal saline may enhance
colonoscopy completion rate, and patient comfort during colonoscopy and during recovery from
colonoscopy.
We propose randomising consenting adult patients attending outpatient colonoscopy to one of
two treatment arms:
(i) A control arm, with standard sedation and monitoring during colonoscopy, and infusion of
normal saline if systolic BP ≤ 95 mmHg for more than 3 minutes (two observation periods)
until completion of the procedure;
(ii) A treatment arm, with pre-hydration with an infusion of 1.0 litre of normal saline
immediately prior to colonoscopy.
Outcome measures include colonoscopy completion rates, hypotension during or after
colonoscopy, and patient ratings of comfort and satisfaction.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02503696 -
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
|
N/A | |
Completed |
NCT01063231 -
Evaluation of PillCam™ Colon 2 in Visualization of the Colon
|
Phase 3 | |
Terminated |
NCT01119027 -
Assessing Effectiveness of Laparoscopic Colorectal Surgical Skills
|
N/A | |
Completed |
NCT04074577 -
Computer Aided Detection, Tandem Colonoscopy Study
|
N/A | |
Not yet recruiting |
NCT04087824 -
Deep Learning Algorithm for Recognition of Colonic Segments.
|
N/A | |
Completed |
NCT03559543 -
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
|
Phase 2 | |
Terminated |
NCT02503631 -
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
|
||
Completed |
NCT01600209 -
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
|
N/A | |
Completed |
NCT01260168 -
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
|
N/A | |
Completed |
NCT00604162 -
PillCam™ Colon Capsule Endoscopy (PCCE) in the Visualization of the Colon
|
Phase 3 | |
Recruiting |
NCT04598880 -
Comparison of 1 Liter PEG With Ascorbate and Sodium Picosulfate / Magnesium Citrate for High Quality Colon Cleansing
|
Phase 4 | |
Completed |
NCT01738425 -
A Clinical Phase I Study on GIC-1001 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04080843 -
Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients
|
Phase 2 | |
Terminated |
NCT04644315 -
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
|
Phase 2 | |
Completed |
NCT02291445 -
Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®), a Pharmacokinetic Study
|
Phase 2 | |
Completed |
NCT03037385 -
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03139942 -
Optical Polyp Testing for In Vivo Classification
|
N/A | |
Completed |
NCT04263818 -
Endoscopist and Endoscope Motions During Colonoscopy
|
N/A | |
Recruiting |
NCT05923918 -
A Study to Evaluate Safety and Efficacy of PBK_M2101
|
Phase 3 | |
Completed |
NCT02647866 -
Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis
|
Phase 2 |